UPDATE 2-Genelabs drug fails late-stage clinical trial
527077
Genelabs Technologies Inc. (GNLB.O: Quote, Profile, Research) said on Tuesday that a late-stage trial of its drug to limit bone loss in women with lupus disease failed to work, sending the company&#39;s shares down 75 percent.
725490
Genelabs Technologies Inc. GNLB.O  said on Tuesday that a late-stage trial of its drug to limit  bone loss in women with lupus disease failed to work, sending  the company's shares down 75 percent.
22568
AstraZeneca Plc suffered its third  setback in two months on Friday as lung cancer drug Iressa  failed to help patients live longer in a major clinical trial,  sending its shares down as much as 9.2 percent.
488668
MedImmune Inc. said yesterday it has ended advanced human testing of its drug Vitaxin to treat rheumatoid arthritis and psoriasis because it failed to show clinical benefits in preliminary results.
538251
A much-watched Alzheimer&#39;s medicine Forest Laboratories (nyse: FRX - news - people ) was developing with Germany&#39;s Merz failed to show a statistically significant benefit in a clinical trial.
550692
NEW YORK - Today at the UBS Global Life Sciences Conference, AtheroGenics was met with pointed skepticism over trial results for its drug, AGI-1067.
505877
Bayer HealthCare stopped a late-stage trial of Nexavar in patients with non-small cell lung cancer after a monitoring committee concluded the study would not improve overall survival.
235475
The outcome of a clinical trial that failed to show Zetia has any benefits adds to concerns over the drug.
64788
Pfizer Inc. on Tuesday said its experimental drug for a deadly form of stomach cancer proved safe and effective in a late-stage trial, prompting researchers to halt the study seven months ahead of schedule.
142646
A new antibody treatment for Alzheimer&#39;s has apparently halted its progression in a small human trial. The treatment lowers the amount of beta peptide in the brain, thought to be the cause of
429530
Shares of biotech firm Pharmos Corp. plunged 77 percent in premarket activity on Monday, after the company reported a late-stage trial of dexanabinol failed to demonstrate efficacy in treating severe traumatic brain injury.
208170
Isis Pharmaceuticals Inc. said on Thursday a trial of its experimental drug for Crohn's disease did not work in a late stage clinical trial.
747560
Shares in cancer researcher Peplin Biotech Ltd fell almost 27 per cent in late trading Monday after the company said it would discontinue its collaboration with Allergan Inc for the development of a new skin cancer treatment based on Peplin&#39;s PEP005
594161
Genzyme announces positive study results with a recently acquired drug.
134671
Bayer HealthCare, a U.S.-based unit  of Bayer AG , said on Monday it had stopped a  late-stage trial of Nexavar in patients with non-small cell  lung cancer, after an independent data monitoring committee  said it would not meet the main goal of improved overall  survival.
767331
Biopharma firm ends trials for a promising drug and offloads four commercial products.
37345
Teva's lupus drug fails to meet its primary endpoint in its phase 2 trial.